Effect of Inhibition Soluble Epoxide Hydrolase on Insulin Sensitivity in Humans
Phase of Trial: Phase II
Latest Information Update: 25 May 2018
At a glance
- Drugs GSK 2256294 (Primary)
- Indications Endocrine disorders; Glucose metabolism disorders; Obesity; Prediabetic-state
- Focus Therapeutic Use
- 16 May 2018 Status changed from not yet recruiting to recruiting.
- 05 Apr 2018 New trial record
- 03 Apr 2018 Planned initiation date changed from 1 Apr 2018 to 10 Apr 2018.